Technology
Health
Biotechnology

Autolus Therapeutics

$22.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.45 (-1.95%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell AUTL and other stocks, options, ETFs, and crypto commission-free!

About

Autolus Therapeutics plc American Depositary Share, also called Autolus Therapeutics, is a biopharmaceutical company. It engages in the development of cancer treatments. Read More The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom.

Employees
166
Headquarters
London, Greater London
Founded
2018
Market Cap
906.90M
Price-Earnings Ratio
Dividend Yield
Average Volume
94.98K
High Today
$23.80
Low Today
$22.20
Open Price
$23.00
Volume
19.51K
52 Week High
$53.24
52 Week Low
$19.17

Collections

Technology
Health
Biotechnology
Cancer Prevention
Therapy
Biopharmaceutical
Pharmaceutical
2018 IPO

News

Seeking AlphaMay 14

Autolus Therapeutics PLC. CEO Christian Itin on Q1 2019 Results - Earnings Call Transcript

Autolus Therapeutics PLC (NASDAQ:AUTL) Q1 2019 Earnings Conference Call May 14, 2019 8:30 AM ET Company Participants Silvia Taylor - VP, Corporate Affairs and Communication Christian Itin - Chairman & CEO Andrew Oakley - CFO & SVP Conference Call Participants Biren Amin - Jefferies Matthew Phipps - William Blair & Company Graig Suvannavejh - Goldman Sachs Group Operator Good day, ladies and gentlemen, and welcome to the Autolus Therapeutics First Quarter 2019 Financial Results Conference Call. [Op...

6
Yahoo FinanceMay 7

Autolus Therapeutics to Report First Quarter 2019 Financial Results and Host Conference Call on May 14

13
Yahoo FinanceApr 29

Is Autolus Therapeutics plc (AUTL) A Good Stock To Buy?

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent?

16

Earnings

-$0.69
-$0.63
-$0.58
-$0.52
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.58 per share
Actual
-$0.69 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.